PLK4 and neoplasm: Another Plk4 inhibitor CFI-400945 also triggered mitotic defects in MDA-MB-468 and MDA-MB-231 cells by the dysregulation of centriole number and the induction of polyploidy (158) and inhibited tumor growth in xenograft mouse model established with MDA-MB-468 cells (192).